Medical Market Report

Global Ophthalmic Therapeutics/Drug Market By Type (Anti-allergy, Anti-VEGF Agents, Anti-inflammatory, and Anti-glaucoma), By Application (Dry Eye, Allergies, Glaucoma, Infection, Retinal Disorders, and Uveitis), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 139338
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Ophthalmic Therapeutics/Drug Market is estimated to be valued US$ XX.X million in 2019. The report on Ophthalmic Therapeutics/Drug Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global ophthalmic therapeutics/drug market is segmented on the basis of Type, Application, and geography.

    Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.

    Ophthalmic Therapeutics/Drug Market Scope:

    By type, the market is segmented into Anti-allergy, Anti-VEGF Agents, Anti-inflammatory, and Anti-glaucoma. By Application, the market is divided into Dry Eye, Allergies, Glaucoma, Infection, Retinal Disorders, and Uveitis.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Alcon, Johnson and Johnson Vision Care Inc., Bausch & Lomb Incorporated, Novartis AG, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals Inc., Allergan, Pfizer Inc., Valeant, Bayer AG, Santen Pharmaceuticals Co. Ltd, and Genentech Inc.

    Key Market Segments

    Type

    Anti-allergy

    Anti-VEGF Agents

    Anti-inflammatory

    Anti-glaucoma

    Application

    Dry Eye

    Allergies

    Glaucoma

    Infection

    Retinal Disorders

    Uveitis

    Key Market Players included in the report:

    Alcon

    Johnson and Johnson Vision Care Inc.

    Bausch & Lomb Incorporated

    Novartis AG

    Merck Sharp & Dohme Corp.

    Regeneron Pharmaceuticals Inc.

    Allergan

    Pfizer Inc.

    Valeant

    Bayer AG

    Santen Pharmaceuticals Co. Ltd

    Genentech Inc

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Ophthalmic Therapeutics/Drug Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Ophthalmic Therapeutics/Drug Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Ophthalmic Therapeutics/Drug Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Ophthalmic Therapeutics/Drug Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Ophthalmic Therapeutics/Drug Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Ophthalmic Therapeutics/Drug Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Ophthalmic Therapeutics/Drug sub-markets, depending on key regions (various vital states).
    To analyze Ophthalmic Therapeutics/Drug Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Ophthalmic Therapeutics/Drug Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Ophthalmic Therapeutics/Drug Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Ophthalmic Therapeutics/Drug Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Ophthalmic Therapeutics/Drug Market Overview
    

    3.1. Ophthalmic Therapeutics/Drug Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Ophthalmic Therapeutics/Drug Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Ophthalmic Therapeutics/Drug Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Anti-allergy
    

      4.4. Anti-VEGF Agents
    

      4.5. Anti-inflammatory
    

      4.6. Anti-glaucoma
    

    5. Global Ophthalmic Therapeutics/Drug Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Ophthalmic Therapeutics/Drug Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Dry Eye
    

      5.4. Allergies
    

      5.5. Glaucoma
    

      5.6. Infection
    

      5.7. Retinal Disorders
    

      5.8. Uveitis
    

    6. Global Ophthalmic Therapeutics/Drug Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Ophthalmic Therapeutics/Drug Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Ophthalmic Therapeutics/Drug Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Ophthalmic Therapeutics/Drug Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Ophthalmic Therapeutics/Drug Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Ophthalmic Therapeutics/Drug Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Ophthalmic Therapeutics/Drug Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Alcon
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. Johnson and Johnson Vision Care Inc.
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. Bausch & Lomb Incorporated
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Novartis AG
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. Merck Sharp & Dohme Corp.
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. Regeneron Pharmaceuticals Inc.
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. Allergan
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. Pfizer Inc.
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. Valeant
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

      7.12. Bayer AG
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

      7.13. Santen Pharmaceuticals Co. Ltd
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments
    

      7.14. Genentech Inc
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.